Mitsubishi UFJ Asset Management Co., Ltd.

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1466546 TOKYO, M0

Position in DNA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$301,531

+$117,717 QoQ

Shares Held

30,427

+1.5% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#74

of 183 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mitsubishi UFJ Asset Management Co., Ltd. holds $743,827,492 across 74 Biotechnology names. DNA ranks #29 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	647,193	$321,480,178
2	REGN	Regeneron Pharmaceuticals, Inc.	257,450	$160,530,373
3	ALNY	Alnylam Pharmaceuticals, Inc.	168,664	$50,772,923
4	INCY	Incyte Corp	412,258	$46,733,566
5	RVMD	Revolution Medicines, Inc.	186,924	$35,007,126
6	MRNA	Moderna, Inc.	450,036	$31,516,021
7	INSM	INSMED Inc	289,594	$30,876,512
8	RPRX	Royalty Pharma plc	472,798	$26,509,783

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$301,531	30,427	+1.5%	Shares	Defined	2026-08-07
2026-03-31	$183,814	29,986	-2.4%	Shares	Defined	2026-05-12
2025-12-31	$255,341	30,727	+3.8%	Shares	Defined	2026-02-03
2025-09-30	$431,640	29,605	+0.2%	Shares	Defined	2025-11-12
2025-06-30	$332,392	29,546	-80.8%	Shares	Defined	2025-08-07
2024-03-31	$178,169	153,594	-4.4%	Shares	Defined	2024-05-09
2023-12-31	$271,461	160,628	-28.6%	Shares	Defined	2024-02-08
2023-09-30	$407,316	225,037	+9.7%	Shares	Defined	2023-11-07
2023-06-30	$381,632	205,179	+65.9%	Shares	Defined	2023-08-09
2023-03-31	$164,466	123,659	+7.7%	Shares	Defined	2023-05-08
2022-12-31	$193,956	114,767	+14.7%	Shares	Defined	2023-02-07
2022-09-30	$312,252	100,081	+2.2%	Shares	Defined	2022-11-01
2022-06-30	$233,066	97,927	—	Shares	Defined	2022-08-04
No filing history on record for this holder in this stock.